Patents for A61P 27 - Drugs for disorders of the senses (53,017)
01/1990
01/03/1990EP0348527A1 Antiallergic eye drop
01/02/1990US4891226 Pharmaceutical which can be administered nasally, a process for its preparation, and its use
12/1989
12/28/1989WO1989012949A1 Sealed cool light display and method
12/28/1989WO1989012689A1 Method of obtaining a mixture of ribonucleotides
12/28/1989WO1989012636A1 Tricyclic lipoxygenase inhibiting compounds, compositions, methods of use
12/27/1989CN1038280A Prepn. of formylamide derivatives
12/20/1989EP0347370A2 10-Beta, 11-beta-bridged steroids
12/20/1989EP0346939A1 Tricyclic lipoxygenase inhibiting compounds
12/20/1989CN1038092A Tetralin esters of phenols or benzoic acids
12/19/1989US4888168 Stable ophthalmic preparations containing acetazolamide
12/14/1989WO1989012093A1 Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction
12/14/1989WO1989011854A1 Pharmacological treatment of ocular development
12/13/1989EP0345974A2 Cell-proliferative proteins and isolation thereof
12/06/1989EP0345028A2 Treatment of glaucoma using phosphodiesterase inhibitor
12/06/1989EP0344795A1 Stabilized pharmaceutical composition and method of producing same
12/06/1989EP0344235A1 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension.
12/05/1989CA1263606A1 Non-toxic opthalmic preparations
11/1989
11/28/1989US4883885 Oxolabdanes
11/28/1989US4883800 Diabetes
11/23/1989EP0342396A1 Ophthalmic ointments for the treatment of glaucoma, comprising ergot alkaloids
11/15/1989EP0341264A1 Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction)
11/14/1989US4880813 Method of treatment for allergic rhinitis
11/14/1989US4880785 Viricides
11/02/1989WO1989010126A1 Antiglaucoma compositions containing combinations of alpha-2 agonists and beta-blockers
11/02/1989WO1989010120A1 Antiglaucoma compositions containing combinations of sympathomimetic agents and beta-1 selective beta-blockers
11/02/1989EP0339688A1 Hydroxyphenylthioalkylketones
10/1989
10/25/1989EP0338595A1 Hydroxyphenylthioalkylketoalcohols
10/25/1989EP0338507A2 Use of mabuterol and related compounds for intraocular pressure adjustment
10/24/1989US4876381 Naphthalene derivatives possessing a retinoid-type action, processes for their preparation, and medicinal and cosmetic compositions containing these derivatives
10/24/1989US4876271 Substituted thieno[3,2-b]thiophene-2-sulfonamides as topically active carbonic anhydrase inhibitors
10/24/1989US4876250 Methods for controlling ocular hypertension with angiostatic steroids
10/19/1989WO1989009792A1 Method for potentiating and inhibiting insulin-like growth factor activity
10/19/1989WO1989009773A1 (d)-6-FLUORO-2,3-DIHYDRO-2',5'-DIOXO-SPIRO[4H-1-BENZOPYRAN-4,4'-IMIDAZOLIDINE]-2-CARBOXAMIDE DERIVATIVES, MANUFACTURING PROCESS AND USE THEREOF
10/19/1989WO1989009602A1 An anti-inflammatory factor, method of isolation, and use
10/18/1989EP0337765A2 Acylsulfonamide derivatives of alpha-carbocyclyltoluic acids used as leukotriene antagonists
10/18/1989EP0337689A1 Tetralin esters of phenols or benzoic acids having retinoid like activity
10/18/1989EP0337328A2 Use of ofloxacin or a salt thereof for preparing a topical preparation for treating otopathy
10/17/1989US4874869 Hydantoin derivatives and medicines containing the same
10/11/1989EP0336694A2 An anti-inflammatory factor from milk
10/11/1989EP0336416A1 (d)-6-Fluoro-2,3-dihydro-2',5'-dioxo-spiro[1H-1-Benzopyran-4,4'-imidazolidine]-2-carboxamide derivatives, process for the preparation and use of the derivatives
10/11/1989CN1036135A Growth inhibiting agent and use thereof
10/05/1989WO1989009057A1 Combination of tobramycin and steroids for topical ophthalmic use
10/03/1989US4871764 12-Halogenated forskolin derivatives
10/03/1989US4871742 Administering allopurinol, oxypurinol, or flavonoid
10/03/1989US4871739 Substituted 6H-7,8-dihydrothiapyrano(3,2-D)-pyrimidines as hyopglycemic agents
09/1989
09/26/1989CA1261849A1 L-lysine pyruvate and l-histidine pyruvate
09/26/1989CA1261837A1 4-vinylbenzoic acid derivatives; process for preparing the same and their use as ligands and therapeutic agents
09/26/1989CA1260831A1 Insoluble medicament for a local administration in a human or animal ear
09/21/1989WO1989008452A1 Lacrimal secretion stimulant (lss)
09/20/1989EP0333516A1 Method and composition for opthalmic anesthesia using rodocaine
09/19/1989US4868212 Pharmaceutical and dietary composition
09/19/1989US4868154 Stimulation of tear secretion with melanocyte stimulating hormones
09/06/1989EP0205606B1 Pharmaceutical compositions and their use as mydriatics
09/05/1989US4863922 Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use
09/05/1989US4863912 Use of tetrahydrocortisol in glaucoma therapy
08/1989
08/30/1989EP0330396A2 DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI
08/30/1989EP0329948A2 Use of beta-adrenergic blocking agents in the treatment of the progression of infantile myopia
08/30/1989EP0329932A2 Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments
08/30/1989CN1035116A Heterocyclic oxophthalazinyl acetic acids
08/29/1989US4861789 Dihydro-indene-amine-dihydrooxazoles
08/29/1989US4861580 Composition using salt form of organic acid derivative of alpha-tocopheral
08/23/1989EP0329169A1 N-(lower alkyl)-2-(3'-ureidobenzyl)-pyrrolidines
08/22/1989US4859692 Heterocyclic amide derivatives and pharmaceutical use
08/16/1989EP0327612A1 Pharmaceutical therapeutic use of glutathione derivatives
08/15/1989US4857558 Antiinflammatory agents and-or antiallergens
08/15/1989US4857520 Fused azepinone and azocinone derivatives, processes for their preparation, agents containing them and their use, and intermediates in their preparation
08/10/1989WO1989007105A1 Staurosporin derivatives
08/10/1989WO1989006964A1 Ophthalmic suspensions
08/09/1989EP0326915A1 A locally administrable therapeutic composition for inflammatory disease
08/08/1989US4855283 Immune system stimulants
08/02/1989EP0326196A2 Aqueous pharmaceutical preparation
08/01/1989US4853375 Treating glaucoma; tetracycline and derivatives
08/01/1989US4853219 Angiogenesis inhibitors
07/1989
07/27/1989WO1989006536A1 Growth inhibiting agent and the use thereof
07/26/1989CN1034133A Externally applicable, antiviral pharmaceutical composition accumulating in skin and process for the prepn. preparation of same
07/25/1989US4851415 Ophthalmic use of naphthyridine antibiotics
07/18/1989US4849427 Nedocromil calcium and use thereof in treatment of reversible obstructive airways disease
07/18/1989US4849406 Aprotinin
07/13/1989WO1989006130A1 Antiallergic eye drop
07/12/1989CN1033802A Derivatives of cysteine
07/11/1989US4847289 Thiophene sulfonamide antiglaucoma agents
07/11/1989US4847277 Calcium salt of 10-propyl-2,8-bis(ihtetrazole-5-yl-4h,6h-benzo (1,2-6; 5,4-6'dipyran-4,6-dione
07/11/1989EP0305496A4 Timolol derivatives.
07/11/1989CA1257289A1 1-substituted 4-methoxy-2,3,6-trimethylbenzene derivatives; process for preparing the same and their use as cosmetics
07/04/1989CA1256894A1 Naphtalenic derivatives, their preparation, and cosmetic composition including same
07/04/1989CA1256862A1 Aromatic heterocyclic derivatives and process for their preparation
07/04/1989CA1256804A1 Pharmaceutical compositions comprising one or several aromatic heterocyclic derivatives as active principle
06/1989
06/29/1989WO1989005793A1 N-acyl-n-naphthoylglycines as aldose reductase inhibitors
06/29/1989WO1989005791A1 N-naphthoylglycines as aldose reductase inhibitors
06/28/1989EP0322256A1 N-acyl-N-naphthoylglycines as aldose reductase inhibitors
06/28/1989EP0322255A1 N-acyl-N-naphthoylglycines as aldose reductase inhibitors
06/28/1989EP0322153A2 Heterocyclic oxophtalazinyl acetic acids
06/28/1989EP0321474A1 Water soluble complex of a poly(vinylpyrrolidone) copolymer and d-threo-(1,1'-dihydroxy-1-p-nitrophenylisopropyl) dichloroacetamide
06/27/1989CA1256378A1 Pharmaceutical composition containing at least one naphtalenic derivative as active principle
06/27/1989CA1256375A1 Ophthalmic solution containing pranoprofen
06/20/1989US4840970 Aqueous solution containing lipid-soluble pharmaceutical substance
06/14/1989EP0320438A1 17-Halomethylene estratrienes
06/14/1989EP0320205A2 Renin inhibiting dipeptides, their preparation and compositions containing them
06/14/1989EP0320204A2 Renin inhibiting dipeptides, their preparation and compositions containing them
06/14/1989EP0320164A2 Method for preparing hylan and novel hylan product